Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

P Garcia-Pavia, C Rapezzi, Y Adler, M Arad… - European heart …, 2021 - academic.oup.com
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D …

P Garcia‐Pavia, C Rapezzi, Y Adler… - European journal of …, 2021 - Wiley Online Library
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

Noninvasive imaging to assess atherosclerotic plaque composition and disease activity: coronary and carotid applications

M Daghem, R Bing, ZA Fayad, MR Dweck - Cardiovascular Imaging, 2020 - jacc.org
Cardiovascular disease is one of the leading causes of mortality and morbidity worldwide.
Atherosclerosis imaging has traditionally focused on detection of obstructive luminal …

Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: a systematic review

HSA Tingen, A Tubben, JH Van'T Oever… - European journal of …, 2023 - Springer
Purpose Transthyretin (ATTR) amyloidosis is a progressive protein misfolding disease with
frequent cardiac involvement. This review aims to determine the value of PET in diagnosis …

Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular …

RHJA Slart, AWJM Glaudemans, O Gheysens… - European journal of …, 2021 - Springer
With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in
cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with …

clinical PET/MRI: 2018 update

SM Broski, AH Goenka, BJ Kemp… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to provide an update on clinical PET/MRI,
including current and developing clinical indications and technical developments …

Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden

J Kwiecinski, S Cadet, M Daghem, ML Lassen… - European journal of …, 2020 - Springer
Abstract Purpose 18 F-sodium fluoride (18 F-NaF) has shown promise in assessing disease
activity in coronary arteries, but currently used measures of activity–such as maximum target …

99mTc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis

YM Khor, SAM Cuddy, V Singh, RH Falk, MF Di Carli… - Radiology, 2022 - pubs.rsna.org
Transthyretin cardiac amyloidosis (ATTR-CA) is an overlooked cause of heart failure, with
substantial morbidity and mortality. The emergence of several novel therapies has fueled the …

MR/PET imaging of the cardiovascular system

PM Robson, D Dey, DE Newby, D Berman, D Li… - JACC: Cardiovascular …, 2017 - jacc.org
Cardiovascular imaging has largely focused on identifying structural, functional, and
metabolic changes in the heart. The ability to reliably assess disease activity would have …

Emerging PET tracers in cardiac molecular imaging

SB Singh, SJ Ng, HC Lau, K Khanal, S Bhattarai… - Cardiology and …, 2023 - Springer
Abstract 18F-fluorodeoxyglucose (FDG) and 18F-sodium fluoride (NaF) represent emerging
PET tracers used to assess atherosclerosis-related inflammation and molecular calcification …